Leucine-rich repeat kinase 2 exacerbates neuronal cytotoxicity through phosphorylation of histone deacetylase 3 and histone deacetylation

Neuroanatomical Visualization of the Impaired Striatal Connectivity in Huntington's Disease Mouse Model

beta-Lapachone increases phase II antioxidant enzyme expression via NQO1-AMPK/PI3K-Nrf2/ARE signaling in rat primary astrocytes

GENE THERAPY BY PROTEASOME ACTIVATOR, PA28 gamma, IMPROVES MOTOR COORDINATION AND PROTEASOME FUNCTION IN HUNTINGTON'S DISEASE YAC128 MICE

G2385R and I2020T Mutations Increase LRRK2 GTPase Activity

MiR-126 Regulates Growth Factor Activities and Vulnerability to Toxic Insult in Neurons

LRRK2 G2019S mutation attenuates microglial motility by inhibiting focal adhesion kinase

Leucine-Rich Repeat Kinase 2 (LRRK2) phosphorylates p53 and induces p21(WAF1/CIP1) expression

"An early endosome regulator, Rab5b, is an LRRK2 kinase substrate"

Increased TRPC5 glutathionylation contributes to striatal neuron loss in Huntington's disease